Results

Total Results: 1,541 records

Showing results for "months".

221. Breastfeeding and Health Outcomes for Infants and Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-protocol.pdf
     February 01, 2023 - Health Organization (WHO)6 to recommend that infants be fed breastmilk exclusively for the first 6 months … support continued breastfeeding, along with appropriate complementary foods introduced at about 6 months … Nutrition for healthy term infants: Recommendations from birth to six months. 11/1/2022]. … Systematic review methods for the Pregnancy and Birth to 24 Months Project. … The Pregnancy and Birth to 24 Months Project: a series of systematic reviews on diet and health.

222. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
     May 07, 2010 - direct renin inhibitor For all included studies, please also indicate the longest length (weeks or months … www.effectivehealthcare.ahrq.gov Published Online: May 07, 2010 - EX - Rev - IN AcVAr (specify # weeks or # months … follow-up, or write “NS” if length of follow-up not specified) - IN AcVR (specify # weeks or # months … follow-up, or write “NS” if length of follow-up not specified) - IN ArVR (specify # weeks or # months … the peer review comments are documented and will, for CERs and Technical briefs, be published three months

223. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
     September 01, 2011 - • Oligoarthritis: Affects up to four joints within the first 6 months of illness; may be persistent … involving no more than four joints) or extended (i.e., involving more than four joints after the first 6 months … 2 • Rheumatoid-factor positive (RF+) polyarthritis: Affects five or more joints during the first 6 months … • Rheumatoid-factor negative (RF-) polyarthritis: Affects five or more joints during the first 6 months … responded to a biologic DMARD, randomized discontinuation trials show that continued treatment for from 4 months

224. Appendix C: Fiber Intake and Laxation in People With Normal Bowel Function Report (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-prepub-final-research-appendix-c.xlsx
     January 01, 2024 - thyroid disease, or a psychiatric disorder); taking any medications or supplements in the previous 3 months … antibiotics or any other medical treatment influencing gut transit or intestinal flora for at least 3 months … ; antibiotics within 6 months; constipation; diarrhoea; other gastrointestinal complaint 3 wk 3 wk 5/ … metabolism, to reduce appetite and body weight; body weight gain or loss of at least 5 kg in the 3 months … life expectancy shorter than 5 years, the use of antibiotics, laxatives, prebiotics or probiotics 3 months

225. Fiber-Intake-Final-Appendix-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-final-appendix-c.xlsx
     January 01, 2024 - thyroid disease, or a psychiatric disorder); taking any medications or supplements in the previous 3 months … antibiotics or any other medical treatment influencing gut transit or intestinal flora for at least 3 months … ; antibiotics within 6 months; constipation; diarrhoea; other gastrointestinal complaint 3 wk 3 wk 5/ … anti-inflammatory drug and/or corticosteroid intake, or laxative or antibiotic intake within three months … metabolism, to reduce appetite and body weight; body weight gain or loss of at least 5 kg in the 3 months

226. Disposition of Comments Report for Evaluation and Treatment of Cryptorchidism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_disposition-comments.pdf
     December 11, 2012 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … paragraph, it is stated that 70% descend in the first year of life—it is actually in the first 3-4 months … We know that the data show it is very rare for spontaneous testicular decent after 9 months. … Watchful waiting is only appropriate during a certain time interval-during the first 9 months of life … We have added the phrase, "most occurring in the first three months."

227. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
     February 01, 2008 - The trial comparing 3 months and 8 months neoadjuvant ADT with RP reported greater AEs in the 8-month … One RCT (N=216) found that conformal EBRT combined with 6 months of ADT reduced all-cause mortality, … Median followup was 8 months. … Shorter (3-months) EBRT Low 1 trial (N=378) with an adequate method of allocation. … (8-months) EBRT with ADT • Biochemical/clinical progression or recurrence: The actuarial estimate

228. Fibromyalgia Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fibromyalgia_executive.pdf
     January 01, 2015 - Widespread Pain Index and the Symptom Severity Scale, and (2) a requirement of symptoms for at least 3 months … that compared treatments for fibromyalgia in subgroups of adults and reported outcomes at least 3 months … • Evidence is overwhelmingly short term (3 months). … ,55,63 but in one study females improved more than males at 3 months.4 When PGI-I was the outcome, … The vast majority of studies are short term (3 months), leaving many questions about the durability

229. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alternative-payment-models-protocol.pdf
     December 16, 2024 - The disposition of comments for systematic reviews and technical briefs will be published 3 months after

230. Postpartum Care for Women Up to One Year After Pregnancy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/postpartum-care-one-year-protocol-amendment.pdf
     April 25, 2022 - specifically within 6 days postpartum, between 1 to 6 weeks postpartum, and between 6 weeks and 3 months … ● Outcome measurement: For KQ 1a: within 3 months after giving birth. … For KQ 1b: 3 months to 1 year after giving birth (except interpregnancy interval, unintended … For KQ 1a, timing of interest for outcomes is within 3 months after giving birth. … The Disposition of Comments for systematic reviews will be published 3 months after the publication

231. Data Points 16: Types of Prostate Radiation: Changes across time and geography in the use of prostate radiation technologies for newly diagnosed older cancer patients: 2006-2008 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-radiation_research.pdf
     November 01, 2012 - age 65 who were alive and enrolled in Medicare fee-for-service (FFS) Parts A and B for at least 12 months … The analysis is restricted to men who received radiation therapy within 12 months of the first date … We exclude men who had radical prostatectomy within the 12 months of the first date suggestive of prostate … newly diag- nosed with prostate cancer between 2006 and 2008 who received radiation therapy within 12 months

232. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substanceabuse_hi_impact.pdf
     January 01, 2012 - depending on expert comments received on interventions issued for comment during the preceding six months … followed by a buprenorphine implant placed under the skin in a physician’s office and removed after 6 months … The optimal duration of treatment varies, but is typically in the range of 6 months to a year. … implant system consists a polymer rod that releases a sustained level of buprenorphine for up to 6 months

233. Atrial-Fibrillation-Addendum-140619 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-addendum-140619.pdf
     June 19, 2014 - Insufficient (No studies) All-Cause: SOE=Low (1 study, 110 patients) No events in either arm after 48 months … study, 60 patients) Stroke: SOE= Low (1 study, 144 patients) No events in any arm after 16 months

234. Transparency of Reporting Requirements: Tympanostomy Tubes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research-protocol.pdf
     September 02, 2016 - all KQs, the Eligibility Criteria used will be: Populations All KQs: Ages: infant (28 days to 12 months … ), toddler (13 months to 2 years), early childhood (2 to 5 years), middle childhood (6 to 11 years), … study-specific definitions of “chronic” but use as a standard definition effusion that persists for 3 months … use as a standard definition Three or more well- documented and separate AOM episodes in the past 6 months … or at least four well-documented and separate AOM episodes in the past 12 months with at least one

235. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
     July 13, 2011 - Good or fair quality, controlled observational studies Minimum study duration For all studies: 3 months … observational studies Minimum study duration For RCTs: 6 weeks For observational studies: 3 months … Uncontrolled trials Minimum study duration For RCTs: 6 weeks For observational studies: 3 months … during which the treatment goal is continued absence of depressive symptoms for an additional 4 to 9 months … the peer review comments are documented and will, for CERs and Technical briefs, be published three months

236. Rapid Evidence Product: Misuse of ADHD Prescription Stimulants in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-adhd-prescription-rapid-research.pdf
     July 01, 2025 - : 7.5% of students used ADHD stimulants in past 4 months. … : 14.5% had ever misused; of these, 56.2% had misused at least once in the past 12 months. … : In the past 12 months: 1-9 times 43%, 10-19 times 7%, 20-49 times 4%, 50 or more times 2%. … : 12.2% reported misuse at least once in past 3 months. … : 8% engaged in misuse in past 12 months.

237. Topic 0554 Breastfeeding and Ankyloglossia NSD FINAL SJ (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0653-131114.pdf
     June 14, 2013 - Staff-Generated PICO Population(s): Breastfeeding infants 6 months old or younger with ankyloglossia

238. Microsoft Word - Comparative_Effectiveness_Research_Review_Disposition_of_Comments_Report_Final_120710_refs_delinked1.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_disposition-comments.pdf
     November 01, 2010 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … of the children who participated in the RCT of ESDM were below two years of age (range was 18-30 months … “RCT or case series data detailing either treatment response or adverse events extending beyond 6 months

239. Disposition of Comments for CER 195 Management of Uterine Fibroids (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-195-disposition-comments-uterine-fibroids.pdf
     December 14, 2017 - the authors’ responses to the comments are posted for public viewing on the Web site approximately 3 months … We have noted that this is up to 24 months of follow-up. … Appendix H provides results at up to 6, 12, and 24 months. … Due to safety issues, the use of leuprolide is limited for only 3 months. … Assume it is months, but it could easily be another unit of time.

240. Executive summary_Comparative Effectiveness Review No. 270: Behavioral Interventions for Migraine Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-270-bimp-executive-summary.pdf
     May 01, 2024 - Executive summary_Comparative Effectiveness Review No. 270: Behavioral Interventions for Migraine Prevention Comparative Effectiveness Review Number 270 Behavioral Interventions for Migraine Prevention Executive Summary Main Points • Adults: Interventions including cognitive behavioral ther…